KC, why not focus on Oxy C patch for Ph2 as originally planned?
Why the shift to Oxy M, and others? Surely this has added to delays in Oxy C, capital allocated to Oxy C used for new projects.
POH will not have sufficient funds to complete a Ph3 if they go down this path as originally intended.
Why is a Ph2 necessary?
What discussions have taken place with the FDA?
"No Bioshareswoman is and was not Esra. Period"
Que?
Biosharewomen is Esra...and was not Esra at the same time?
I am thinking BSW is actually Sherlock Buffet myself....
chart update, page-125
-
- There are more pages in this discussion • 31 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
-0.001(33.3%) |
Mkt cap ! $6.338M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.2¢ | $11.50K | 4.335M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 63 | 101422109 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 20872825 | 7 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| AVE (ASX) Chart |